EcoDrugPlus

Ensembl ID : YGL011C
Description: -
81 Possible Orthologues:

Title

Ensembl ID : YGL030W
Description: -
112 Possible Orthologues:

Title

Ensembl ID : YGL031C
Description: -
93 Possible Orthologues:

Title

Ensembl ID : YGL048C
Description: -
86 Possible Orthologues:

Title

Ensembl ID : YGL076C
Description: -
54 Possible Orthologues:

Title

Ensembl ID : YGL103W
Description: -
107 Possible Orthologues:

Title

Ensembl ID : YGL123W
Description: -
129 Possible Orthologues:

Title

Ensembl ID : YGL167C
Description: -
354 Possible Orthologues:

Title

Ensembl ID : YGL189C
Description: -
97 Possible Orthologues:

Title

Ensembl ID : YGL194C
Description: -
37 Possible Orthologues:

Title

Ensembl ID : YGL253W
Description: -
80 Possible Orthologues:

Title

Ensembl ID : YGR027C
Description: -
88 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).